Share Email Print

Proceedings Paper • new

Near infra-red light treatment of Alzheimer’s disease
Author(s): Lechan Tao; Xue Wang; Quanqu Zhou; Xunbin Wei
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Alzheimer's disease (AD) is a chronic neurodegenerative disease. It is generally believed that there are some connections between AD and amyloid protein plaques in the brain. The typical symptoms of AD are memory and spatial learning difficulties, language disorders, loss of motivation and behavioral issues. Currently, the main therapeutic method is pharmacotherapy, which temporarily relieves symptoms, and yet brings with some side effects. Near infrared (NIR) light therapy has been studied in a range of single and multiple irradiation protocols in previous studies and was found beneficial for neuropathology. In our research, we demonstrated the effect of NIR light on AD through transgenic mouse model. We designed an experimental apparatus consisted of a box with a LED array emitting NIR light inside. After the treatment, we assessed the effects of infrared light by testing cognitive performance of mice in Morris water maze, and detecting plaque load by immunofluorescence analysis. Our results show that NIR therapy is able to attenuate the Aβ burden and cognitive deficits in the mouse model. It might provide a novel and safe way to treat AD.

Paper Details

Date Published: 7 March 2019
PDF: 6 pages
Proc. SPIE 10879, Biophotonics and Immune Responses XIV, 108791A (7 March 2019); doi: 10.1117/12.2512618
Show Author Affiliations
Lechan Tao, Shanghai Jiao Tong Univ. (China)
Xue Wang, Shanghai Jiao Tong Univ. (China)
Quanqu Zhou, Shanghai Jiao Tong Univ. (China)
Xunbin Wei, Shanghai Jiao Tong Univ. (China)

Published in SPIE Proceedings Vol. 10879:
Biophotonics and Immune Responses XIV
Wei R. Chen, Editor(s)

© SPIE. Terms of Use
Back to Top